Diabetes is the seventh leading cause of death in the United States. According to the Centers for Disease Control and Prevention, about 29 million people in the US currently have diabetes. Still, as many as 8 million are not yet aware that diabetes is affecting their health.
Signs and symptoms of type 1 and type 2 diabetes with hyperglycemia can include increased thirst, increased urination, increased appetite, fatigue, blurred vision, and nausea. Additional indicators are slow-healing wounds, erectile dysfunction, and menstruation problems, as well as neurological issues.

The Evexia Diagnostics Comprehensive Diabetes Panel can help identify individuals with insulin resistance or prediabetes who are at risk of developing diabetes. This panel incorporates a complete blood count, a comprehensive metabolic panel, and a complete urinalysis. Also included in this panel is antibody testing for type 1 diabetes, hemoglobin A1c with average glucose, GlycoMark, and C-peptide. Another critical component in this panel is a nutrient assessment of vitamin D, zinc, and magnesium, as well as the advanced NMR LipoProfile.

Diabetes autoantibodies help to distinguish between type 1 and type 2 diabetes if the diagnosis is unclear. The presence of one or more of these antibodies indicates type 1 diabetes. Antipancreatic islet cells, insulin autoantibodies, and ZnT8 antibodies are all part of this panel.

This panel comes with a free* Functional Health Report when Evexia Nutraceuticals are recommended. *A $5 fee is applied when recommendations other than Evexia Nutraceuticals are selected.

Evexia Comprehensive Diabetes Panel

Download the Clinical Pearl
Take-Away PDF for this month